Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

ptscowner

May 05, 2022 11:05AM

potofgold

Rank: Treasurer [?]

Points: 1422 [?]

Votes: 29 Score: 1.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

in response to

Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

ptscowner

posted on May 05, 2022 11:49AM

Finally. Something. Good way to get Q2 up and going.

Hope this is a good solid base for something or somethings.

Now give us Q1 financials.

Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

ptscowner

May 05, 2022 12:50PM

Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

ptscowner

May 05, 2022 12:50PM

Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement

ptscowner

May 06, 2022 10:28AM

Re: Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement